Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $40.0000 (-1.72%) ($39.7000 - $41.6000) on Wed. Nov. 4, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.08% (three month average) | RSI | 33 | Latest Price | $40.0000(-1.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.8% a day on average for past five trading days. | Weekly Trend | CAPR declines -5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) PEJ(7%) VT(7%) XLF(7%) EWG(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.04% in a week (0% probabilities). VIXM(-5%) TLT(-5%) GLD(-3%) BND(-3%) VCSH(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.04% (StdDev 4.08%) | Hourly BBV | 0 () | Intraday Trend | -3.8% | | | |
|
1 - 5 Day Possible Target | $31.71(-20.73%) | Resistance Level | $42.74 | 5 Day Moving Average | $40.5(-1.23%) | 10 Day Moving Average | $40.86(-2.1%) | 20 Day Moving Average | $42.74(-6.41%) | To recent high | -16% | To recent low | 3.6% | Market Cap | $788m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |